By Julien Salaberry
Feb 24, 2015
The Biotechnology Industry Organization (BIO) has released a lengthy white paper on the past decade of VC funding for the biotech sector. Its headline finding is that venture funding for biotech R&D fell by 21% between the five-year period before the financial crisis (2004-2008) and the subsequent five years (2009-2013).
More interesting, however, is where the big funding cuts are occurring. Namely, in areas of the largest medical need. For…